← Teladoc Health, Inc. TDOC
Market Price
$6.81
Market Cap
$1.25B
P/E Ratio
N/A
Revenue (FY 2025)
↓-1.5% YoY
$2.53B
3-Yr CAGR: 1.7%
Net Income
↑80.0% YoY
-$200.32M
Net Margin: -7.9%
Free Cash Flow
↑0.9% YoY
$285.46M
FCF Yield: 22.75%
EPS (Diluted)
↑80.6% YoY
$-1.14
Basic: $-1.14
Return on Equity
Efficiency
-14.5%
ROA: -187.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TDOC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $123.2M | — | $91.2M | $-74.2M | — | — | — | $-51.9M | $-54.0M | — |
| FY 2017 | $233.3M | +89.4% | $171.7M | $-106.8M | -43.9% | — | — | $-34.4M | $-37.1M | +31.3% |
| FY 2018 | $417.9M | +79.1% | $289.2M | $-97.1M | +9.1% | — | — | $-4.9M | $-8.9M | +76.1% |
| FY 2019 | $553.3M | +32.4% | $368.8M | $-98.9M | -1.8% | $-1.38 | — | $29.9M | $26.4M | +397.1% |
| FY 2020 | $1,094.0M | +97.7% | $703.1M | $-485.1M | -390.7% | $-5.36 | -288.4% | $-53.5M | $-57.5M | -318.3% |
| FY 2021 | $2,032.7M | +85.8% | $1,382.4M | $-428.8M | +11.6% | $-2.73 | +49.1% | $194.0M | $185.5M | +422.3% |
| FY 2022 | $2,406.8M | +18.4% | $1,662.9M | $-13,659.5M | -3,085.6% | $-84.60 | -2,998.9% | $189.3M | $172.8M | -6.8% |
| FY 2023 | $2,602.4M | +8.1% | $1,842.4M | $-220.4M | +98.4% | $-1.34 | +98.4% | $350.0M | $338.6M | +95.9% |
| FY 2024 | $2,569.6M | -1.3% | $1,818.3M | $-1,001.2M | -354.4% | $-5.87 | -338.1% | $293.7M | $282.9M | -16.4% |
| FY 2025 | $2,530.0M | -1.5% | $1,758.4M | $-200.3M | +80.0% | $-1.14 | +80.6% | $294.4M | $285.5M | +0.9% |
Valuation
Market Price
$6.81
Market Cap
$1.25B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
0.89
FCF Yield
22.75%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
69.50%
Operating Margin
-10.39%
Net Margin
-7.92%
Return on Equity (ROE)
-14.46%
Return on Assets (ROA)
-187.19%
Asset Turnover
23.64x
Revenue 3-Yr CAGR
1.68%
Financial Health & Liquidity
Current Ratio
0.26
Cash Ratio
1.93
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$781.08M
Total Debt
N/A
Book Value / Share
$7.68
Cash Flow Efficiency
Operating Cash Flow
$294.36M
Capital Expenditures (CapEx)
$8.89M
Free Cash Flow
$285.46M
OCF / Revenue
11.63%
FCF / Revenue
11.28%
FCF 3-Yr CAGR
18.21%
Per Share Metrics
EPS (Diluted)
$-1.14
EPS (Basic)
$-1.14
Dividends / Share
N/A
Book Value / Share
$7.68
EPS YoY Growth
80.58%
Balance Sheet (FY 2025)
Total Assets
$107.02M
Total Liabilities
$404.74M
Stockholders' Equity
$1.39B
Current Assets
$107.02M
Current Liabilities
$404.74M